Literature DB >> 10099126

The effect of route of immunization on mucosal immunity and protection.

T Lehner1, Y Wang, L Ping, L Bergmeier, E Mitchell, M Cranage, G Hall, M Dennis, N Cook, C Doyle, I Jones.   

Abstract

In macaques, the route of immunization has a profound effect on the immune response. Augmenting rectal or vaginal immunization with oral or nasal immunization enhanced the secretory IgA, serum IgG, and T cell responses. However, targeted iliac lymph node (TILN) immunization with recombinant simian immunodeficiency virus (SIV) gp120 and p27 elicited the most consistent mucosal antibody responses in the rectum, vagina, urine, seminal fluid, and blood. Both mucosal and TILN immunization induced specific CD4+ T cell proliferative responses in the iliac lymph nodes, which drain these mucosal surfaces, and in the splenic and circulating T cells. Rectal mucosal challenge with cell-free SIV induced total protection in 4 of 7 macaques that were immunized by the TILN route, and, compared with unimmunized macaques or those immunized by the mucosal route (P<.001), it induced a >90% decrease in virus load in 3 of them. Protection from mucosal rectal infection with SIV was significantly associated with an increase in the CD8 suppressor factor (which was generated by the iliac lymph node), RANTES, and MIP-1beta (P<.01).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10099126     DOI: 10.1086/314809

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent.

Authors:  Kristen V Khanna; Kevin J Whaley; Larry Zeitlin; Thomas R Moench; Karim Mehrazar; Richard A Cone; Zhaohao Liao; James E K Hildreth; Timothy E Hoen; Leonard Shultz; Richard B Markham
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  DNA-MVA vaccine protection after X4 SHIV challenge in macaques correlates with day-of-challenge antiviral CD4+ cell-mediated immunity levels and postchallenge preservation of CD4+ T cell memory.

Authors:  Mariana Manrique; Ewa Micewicz; Pamela A Kozlowski; Shainn-Wei Wang; Deepti Aurora; Robert L Wilson; Musie Ghebremichael; Gail Mazzara; David Montefiori; Angela Carville; Keith G Mansfield; Anna Aldovini
Journal:  AIDS Res Hum Retroviruses       Date:  2008-03       Impact factor: 2.205

3.  Cervicovaginal lamina propria lymphocytes: phenotypic characterization and their importance in cytotoxic T-lymphocyte responses to simian immunodeficiency virus SIVmac251.

Authors:  Liljana Stevceva; Brian Kelsall; Janos Nacsa; Marcin Moniuszko; Zdenek Hel; Elzbieta Tryniszewska; Genoveffa Franchini
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  A DNA prime-oral Listeria boost vaccine in rhesus macaques induces a SIV-specific CD8 T cell mucosal response characterized by high levels of alpha4beta7 integrin and an effector memory phenotype.

Authors:  Paul Neeson; Jean Boyer; Sanjeev Kumar; Mark G Lewis; Lennox Mattias; Ron Veazey; David Weiner; Yvonne Paterson
Journal:  Virology       Date:  2006-08-09       Impact factor: 3.616

5.  Lack of simian immunodeficiency virus (SIV) specific IgA response in the intestine of SIV infected rhesus macaques.

Authors:  F Schäfer; S Kewenig; N Stolte; C Stahl-Hennig; A Stallmach; F-J Kaup; M Zeitz; T Schneider
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

6.  Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses.

Authors:  Kristina Abel; Lara Compton; Tracy Rourke; David Montefiori; Ding Lu; Kristina Rothaeusler; Linda Fritts; Kristen Bost; Christopher J Miller
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

7.  Newcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in Guinea pigs.

Authors:  Sunil K Khattar; Sweety Samal; Anthony L Devico; Peter L Collins; Siba K Samal
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

8.  Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques.

Authors:  Brian J Rybarczyk; David Montefiori; Philip R Johnson; Ande West; Robert E Johnston; Ronald Swanstrom
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial.

Authors:  Gabriela Senti; Bettina M Prinz Vavricka; Iris Erdmann; Mella I Diaz; Richard Markus; Stephen J McCormack; John J Simard; Brunello Wüthrich; Reto Crameri; Nicole Graf; Pål Johansen; Thomas M Kündig
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-10       Impact factor: 11.205

10.  Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations.

Authors:  Anthony D Cristillo; Maria Grazia Ferrari; Lauren Hudacik; Brad Lewis; Lindsey Galmin; Britany Bowen; DeVon Thompson; Nikolai Petrovsky; Phillip Markham; Ranajit Pal
Journal:  J Gen Virol       Date:  2011-01       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.